Similar articles

• Levodopa and anticholinergic drugs in Parkinsonism.

  Burn JH. Burn JH. Br Med J. 1971 Jun 26;2(5764):773-4. doi: 10.1136/bmj.2.5764.773-d. Br Med J. 1971. PMID: 5090790 Free PMC article. No abstract available.
• [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].

  Levin SL. Levin SL. Zh Nevropatol Psikhiatr Im S S Korsakova. 1972;72(9):1418-26. Zh Nevropatol Psikhiatr Im S S Korsakova. 1972. PMID: 4349303 Review. Russian. No abstract available.
• Levodopa: a review of its pharmacological properties and therapeutic use with particular reference to Parkinsonism.

  Brogden RN, Speight TM, Avery GS. Brogden RN, et al. Drugs. 1971;2(4):262-400. doi: 10.2165/00003495-197102040-00002. Drugs. 1971. PMID: 4340597 Review. No abstract available.
• L-Dopa and Parkinsonism.

  Calne DB, Sandler M. Calne DB, et al. Nature. 1970 Apr 4;226(5240):21-4. doi: 10.1038/226021a0. Nature. 1970. PMID: 4907560 Review. No abstract available.
• [Preliminary observations on the use of intravenous amantadine and of the association of oral amantadine with anticholinergic drugs and with levo-dopa in the treatment of Parkinson's disease].

  Fasano VA, Urciuoli R, Broggi G. Fasano VA, et al. Minerva Med. 1970 Jul 4;61(53):2895-903. Minerva Med. 1970. PMID: 5428170 Italian. No abstract available.